[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]
- PMID: 32075365
- DOI: 10.3760/cma.j.issn.1001-0939.2020.0019
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]
Abstract
At the end of December 2019, a novel coronavirus (COVID-19) caused an outbreak in Wuhan, and has quickly spread to all provinces in China and 26 other countries around the world, leading to a serious situation for epidemic prevention. So far, there is still no specific medicine. Previous studies have shown that chloroquine phosphate (chloroquine) had a wide range of antiviral effects, including anti-coronavirus. Here we found that treating the patients diagnosed as novel coronavirus pneumonia with chloroquine might improve the success rate of treatment, shorten hospital stay and improve patient outcome. In order to guide and regulate the use of chloroquine in patients with novel coronavirus pneumonia, the multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia developed this expert consensus after extensive discussion. It recommended chloroquine phosphate tablet, 500mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of novel coronavirus pneumonia and without contraindications to chloroquine.
自2019年12月,武汉暴发了一种新型冠状病毒病(COVID-19),迅速蔓延至我国各省市及全球26个国家,防疫情势十分严峻。但是目前尚无特效药物。磷酸氯喹(简称氯喹)具有广泛抗病毒及抗冠状病毒的作用,临床研究结果显示氯喹或可提高新型冠状病毒肺炎患者的救治成功率、缩短住院时间及改善预后。为指引并规范氯喹在新型冠状病毒肺炎中的使用,广东省科技厅、广东省卫生健康委氯喹治疗新冠状病毒肺炎多中心协作组经充分讨论后,制定本专家共识,对确诊为新型冠状病毒肺炎轻型、普通型和重型患者,排除氯喹禁忌证后,可以使用磷酸氯喹片每次500 mg,2次/d,疗程10 d。.
Keywords: Chloroquine; Novel coronavirus pneumonia.
Similar articles
-
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188. doi: 10.3760/cma.j.issn.1001-0939.2020.03.009. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32164085 Chinese.
-
[Management and clinical thinking of Coronavirus Disease 2019].Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 3;28(0):E002. doi: 10.3760/cma.j.issn.1007-3418.2020.0002. Online ahead of print. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32125126 Chinese.
-
Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports.Med Acupunct. 2021 Feb 1;33(1):92-102. doi: 10.1089/acu.2020.1432. Epub 2021 Feb 16. Med Acupunct. 2021. PMID: 33613817 Free PMC article.
-
Statistical analysis and visualization of the potential cases of pandemic coronavirus.Virusdisease. 2020 Jun;31(2):204-208. doi: 10.1007/s13337-020-00610-1. Epub 2020 Jun 10. Virusdisease. 2020. PMID: 32656312 Free PMC article.
-
Chinese guidelines related to novel coronavirus pneumonia.J Mark Access Health Policy. 2020 Oct 8;8(1):1818446. doi: 10.1080/20016689.2020.1818446. J Mark Access Health Policy. 2020. PMID: 33133431 Free PMC article. Review.
Cited by
-
Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model.Front Pharmacol. 2022 Nov 30;13:1051694. doi: 10.3389/fphar.2022.1051694. eCollection 2022. Front Pharmacol. 2022. PMID: 36532753 Free PMC article.
-
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.PLoS One. 2022 Sep 29;17(9):e0273526. doi: 10.1371/journal.pone.0273526. eCollection 2022. PLoS One. 2022. PMID: 36173983 Free PMC article.
-
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.medRxiv. 2022 Aug 16:2022.01.10.22269008. doi: 10.1101/2022.01.10.22269008. Preprint. medRxiv. 2022. PMID: 35043124 Free PMC article. Updated.
-
Pharmaceutical messianism and the COVID-19 pandemic.Soc Sci Med. 2022 Jan;292:114567. doi: 10.1016/j.socscimed.2021.114567. Epub 2021 Nov 14. Soc Sci Med. 2022. PMID: 34794852 Free PMC article.
-
Potential of Malawi's medicinal plants in Covid-19 disease management: A review.Malawi Med J. 2021 Jun;33(2):85-107. doi: 10.4314/mmj.v33i2.4. Malawi Med J. 2021. PMID: 34777704 Free PMC article. Review.
Publication types
Grant support
- 2020B111113001/Emergency program for major public health event of Ministry of Science and Technology, Department of Science and Technology of Guangdong Province
- 2020GZR110106003/Guangzhou Regenerative Medicine and Health Guangdong Laboratory: Evaluation of clinical efficacy of chloroquine on 2019 novel coronavirus pneumonia
LinkOut - more resources
Full Text Sources
